[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Bevacizumab Industry Market Analysis & Forecast 2018-2023

July 2018 | 104 pages | ID: C71D7EBD139EN
S&P Consulting

US$ 3,120.00 US$ 3,900.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the China Bevacizumab Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

China Bevacizumab Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Bevacizumab Market: Application Segment Analysis
Hospitals
Ambulatory surgical centers
Others

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
China Bevacizumab Industry Market Analysis & Forecast 2018-2023

CHAPTER 1 BEVACIZUMAB MARKET OVERVIEW

1.1 Product Overview and Scope of Bevacizumab
1.2 Bevacizumab Market Segmentation by Type
  1.2.1 China Production Market Share of Bevacizumab by Type 1n 2017
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Bevacizumab Market Segmentation by Application
  1.3.1 Bevacizumab Consumption Market Share by Application in 2017
  1.3.2 Hospitals
  1.3.3 Ambulatory surgical centers
  1.3.4 Others
1.4 China Market Size Sales (Value) and Revenue (Volume) of Bevacizumab (2013-2023)

CHAPTER 2 CHINA ECONOMIC IMPACT ON BEVACIZUMAB INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Bevacizumab Industry

CHAPTER 3 CHINA BEVACIZUMAB MARKET COMPETITION BY MANUFACTURERS

3.1 China Bevacizumab Production and Share by Manufacturers (2016 and 2017)
3.2 China Bevacizumab Revenue and Share by Manufacturers (2016 and 2017)
3.3 China Bevacizumab Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Bevacizumab Manufacturing Base Distribution, Production Area and Product Type
3.5 Bevacizumab Market Competitive Situation and Trends
  3.5.1 Bevacizumab Market Concentration Rate
  3.5.2 Bevacizumab Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA BEVACIZUMAB CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2013-2018)

4.1 China Bevacizumab Capacity, Production and Growth (2013-2018)
4.2 China Bevacizumab Revenue and Growth (2013-2018)
4.3 China Bevacizumab Production, Consumption, Export and Import (2013-2018)

CHAPTER 5 CHINA BEVACIZUMAB PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Bevacizumab Production and Market Share by Type (2013-2018)
5.2 China Bevacizumab Revenue and Market Share by Type (2013-2018)
5.3 China Bevacizumab Price by Type (2013-2018)
5.4 China Bevacizumab Production Growth by Type (2013-2018)

CHAPTER 6 CHINA BEVACIZUMAB MARKET ANALYSIS BY APPLICATION

6.1 China Bevacizumab Consumption and Market Share by Application (2013-2018)
6.2 China Bevacizumab Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA BEVACIZUMAB MANUFACTURERS ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Business Overview
7.2 Allergan
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Business Overview
7.3 Alnylam Pharmaceuticals
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Business Overview
7.4 Amgen
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Business Overview
7.5 Angstrom Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.5.4 Business Overview
7.6 Acceleron Pharma
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Business Overview
7.7 Biocon
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Business Overview
7.8 Bionomics
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Business Overview
7.9 CASI Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Business Overview


CHAPTER 8 BEVACIZUMAB MANUFACTURING COST ANALYSIS

8.1 Bevacizumab Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Bevacizumab

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Bevacizumab Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Bevacizumab Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA BEVACIZUMAB MARKET FORECAST (2018-2023)

12.1 China Bevacizumab Production, Revenue Forecast (2018-2023)
12.2 China Bevacizumab Production, Consumption Forecast by Regions (2018-2023)
12.3 China Bevacizumab Production Forecast by Type (2018-2023)
12.4 China Bevacizumab Consumption Forecast by Application (2018-2023)
12.5 Bevacizumab Price Forecast (2018-2023)

CHAPTER 13 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab
Figure China Production Market Share of Bevacizumab by Type 1n 2017
Table Bevacizumab Consumption Market Share by Application in 2017
Figure China Bevacizumab Revenue (Million USD) and Growth Rate (2013-2023)
Table China Bevacizumab Capacity of Key Manufacturers (2016 and 2017)
Table China Bevacizumab Capacity Market Share of Key Manufacturers (2016 and 2017)
Figure China Bevacizumab Capacity of Key Manufacturers in 2016
Figure China Bevacizumab Capacity of Key Manufacturers in 2017
Table China Bevacizumab Production of Key Manufacturers (2016 and 2017)
Table China Bevacizumab Production Share by Manufacturers (2016 and 2017)
Figure 2015 Bevacizumab Production Share by Manufacturers
Figure 2016 Bevacizumab Production Share by Manufacturers
Table China Bevacizumab Revenue (Million USD) by Manufacturers (2016 and 2017)
Table China Bevacizumab Revenue Share by Manufacturers (2016 and 2017)
Table 2015 China Bevacizumab Revenue Share by Manufacturers
Table 2016 China Bevacizumab Revenue Share by Manufacturers
Table China Market Bevacizumab Average Price of Key Manufacturers (2016 and 2017)
Figure China Market Bevacizumab Average Price of Key Manufacturers in 2016
Table Manufacturers Bevacizumab Manufacturing Base Distribution and Sales Area
Table Manufacturers Bevacizumab Product Type
Figure Bevacizumab Market Share of Top 3 Manufacturers
Figure Bevacizumab Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Bevacizumab Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
Figure Church & Dwight Bevacizumab Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Pfizer Bevacizumab Market Share (2013-2018)
Table Allergan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Allergan Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Allergan Bevacizumab Market Share (2013-2018)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Alnylam Pharmaceuticals Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Alnylam Pharmaceuticals Bevacizumab Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Amgen Bevacizumab Market Share (2013-2018)
Table Angstrom Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Angstrom Pharmaceuticals Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Angstrom Pharmaceuticals Bevacizumab Market Share (2013-2018)
Table Acceleron Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acceleron Pharma Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Acceleron Pharma Bevacizumab Market Share (2013-2018)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Biocon Bevacizumab Market Share (2013-2018)
Table Bionomics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bionomics Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table Bionomics Bevacizumab Market Share (2013-2018)
Table CASI Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CASI Pharmaceuticals Bevacizumab Production, Revenue, Price and Gross Margin (2013-2018)
Table CASI Pharmaceuticals Bevacizumab Market Share (2013-2018)
Figure Production Revenue Share of Bevacizumab by Type (2013-2018)
Figure 2015 Revenue Market Share of Bevacizumab by Type
Table China Bevacizumab Price by Type (2013-2018)
Figure China Bevacizumab Production Growth by Type (2013-2018)
Table China Bevacizumab Consumption by Application (2013-2018)
Table China Bevacizumab Consumption Market Share by Application (2013-2018)
Figure China Bevacizumab Consumption Market Share by Application in 2016
Table China Bevacizumab Consumption Growth Rate by Application (2013-2018)
Figure China Bevacizumab Consumption Growth Rate by Application (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab
Figure Manufacturing Process Analysis of Bevacizumab
Figure Bevacizumab Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Major Manufacturers in 2016
Table Major Buyers of Bevacizumab
Table Distributors/Traders List
Figure China Bevacizumab Capacity, Production and Growth Rate Forecast (2018-2023)
Figure China Bevacizumab Revenue and Growth Rate Forecast (2018-2023)
Table China Bevacizumab Production, Import, Export and Consumption Forecast (2018-2023)
Table China Bevacizumab Production Forecast by Type (2018-2023)
Table China Bevacizumab Consumption Forecast by Application (2018-2023)

COMPANIES MENTIONED

Pfizer Allergan Alnylam Pharmaceuticals Amgen Angstrom Pharmaceuticals Acceleron Pharma Biocon Bionomics CASI Pharmaceuticals


More Publications